[Common bile duct fistula caused by hepatic arterial infusion chemotherapy].
We often use hepatic arterial infusion chemotherapy to control recurrence of metastatic cancer of liver. Recently, we encountered a case of common bile duct fistula caused by hepatic arterial infusion chemotherapy. A 61-year-old man had undergone right hepatic lobectomy for liver metastasis of gastric cancer, 7 months after total gastrectomy. A hepatic arterial infusion catheter was placed. Since then he has received continuous and/or bolus hepatic artery infusion of 5-FU, ADR and CDDP+5-FU. There was a recurrence of gastric cancer in segment 2 of the liver. On his second admission, when we administered contrast medium to the infusion port, a common bile duct was found.
Ohori
M
M
Dept. of Surgery, Tokyo Metropolitan Bokutoh Hospital.
Umekita
N
N
Maeshiro
T
T
Miyamoto
S
S
Yamada
F
F
Awane
Y
Y
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001658:Biliary Fistula / Q000209:etiology*; D002404:Catheterization / Q000009:adverse effects* / Q000295:instrumentation; D003137:Common Bile Duct Diseases / Q000209:etiology*; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000009:adverse effects* / Q000295:instrumentation; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000473:pathology